PanTher Therapeutics: Funding, Investors & Team (Sep 2026)
PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
PanTher Therapeutics has raised $14.2M across 2 funding rounds on record, the most recent an undisclosed round announced in Jun 2023.
PanTher Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2023.
PanTher Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
PanTher Therapeutics raised $14.2M in a Grant announced in Aug 2022.
10 months later, an undisclosed round was announced in Jun 2023 with no disclosed amount.
PanTher Therapeutics Founders and Leadership Team
Contact details for the PanTher Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →PanTher Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like PanTher Therapeutics in Biotechnology and Cambridge
Companies Similar to PanTher Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
PanTher Therapeutics Funding FAQs
What does PanTher Therapeutics do?
PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
How much funding has PanTher Therapeutics raised?
PanTher Therapeutics has raised $14.2M across 2 rounds on record.
When did PanTher Therapeutics last raise funding?
PanTher Therapeutics' most recent funding round on record was announced in Jun 2023. The amount was not disclosed.
Who founded PanTher Therapeutics?
FundedIQ lists Laura Indolfi (Founder) at PanTher Therapeutics.
Where is PanTher Therapeutics headquartered?
PanTher Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does PanTher Therapeutics have?
PanTher Therapeutics is in the 11-50 employee band.
About FundedIQ's PanTher Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PanTher Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.